These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 26255258)

  • 1. The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District.
    Asteria CR; Pucciarelli S; Gerard L; Mantovani N; Pagani M; Boccia L; Ricci P; Troiano L; Lucchini G; Pulica C
    Int J Colorectal Dis; 2015 Dec; 30(12):1627-37. PubMed ID: 26255258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent Long-Term Detection Rates of Proximal and Distal Advanced Neoplasia in Fecal Immunochemical Test Screening Programs: A Retrospective Cohort Study.
    Zorzi M; Hassan C; Capodaglio G; Narne E; Turrin A; Baracco M; Dal Cin A; Fiore A; Martin G; Repici A; Rex D; Rugge M
    Ann Intern Med; 2018 Nov; 169(9):602-609. PubMed ID: 30285055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of interval colorectal cancers following screening by fecal immunochemical test may predict worse outcomes and prompt ethical concerns: a 6-year population-based cohort study in a full district.
    Asteria CR; Lucchini G; Guarda L; Ricci P; Pagani M; Boccia L
    Eur J Cancer Prev; 2019 Jan; 28(1):17-26. PubMed ID: 29111981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
    Engstrand J; Nilsson H; Strömberg C; Jonas E; Freedman J
    BMC Cancer; 2018 Jan; 18(1):78. PubMed ID: 29334918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of family history on survival in patients with colon and rectal cancer.
    Lee SD; Kim BC; Han KS; Hong CW; Sohn DK; Park JW; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
    J Dig Dis; 2014 Mar; 15(3):108-15. PubMed ID: 24304621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of patients with symptom- and screening-detected colorectal cancer.
    Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
    Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
    Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
    Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of primary tumour location after curative resection in Stage I-III colorectal cancer: a single-centre retrospective study.
    Inoue M; Kanemitsu Y; Tsukamoto S; Moritani K; Takamizawa Y; Daiko H
    Jpn J Clin Oncol; 2024 Jul; 54(7):753-760. PubMed ID: 38535894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New trend in colorectal cancer in Germany: are young patients at increased risk for advanced colorectal cancer?
    Ambe PC; Jansen S; Zirngibl H
    World J Surg Oncol; 2017 Aug; 15(1):159. PubMed ID: 28835275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
    Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
    Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer.
    Krul MF; Elferink MAG; Kok NFM; Dekker E; Lansdorp-Vogelaar I; Meijer GA; Nagtegaal ID; Breekveldt ECH; Ruers TJM; van Leerdam ME; Kuhlmann KFD
    Clin Gastroenterol Hepatol; 2023 Mar; 21(3):797-807.e3. PubMed ID: 36116753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
    Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
    Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node retrieval in colorectal cancer: determining factors and prognostic significance.
    Betge J; Harbaum L; Pollheimer MJ; Lindtner RA; Kornprat P; Ebert MP; Langner C
    Int J Colorectal Dis; 2017 Jul; 32(7):991-998. PubMed ID: 28210855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening.
    Abdelsattar ZM; Wong SL; Regenbogen SE; Jomaa DM; Hardiman KM; Hendren S
    Cancer; 2016 Mar; 122(6):929-34. PubMed ID: 26808454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
    Sasaki K; Andreatos N; Margonis GA; He J; Weiss M; Johnston F; Wolfgang C; Antoniou E; Pikoulis E; Pawlik TM
    J Surg Oncol; 2016 Dec; 114(7):803-809. PubMed ID: 27792291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years.
    Idigoras Rubio I; Arana-Arri E; Portillo Villares I; Bilbao Iturribarrria I; Martínez-Indart L; Imaz-Ayo N; de la Cruz M; de Castro V; López de Munain A; Torrejón Perez I; Gutiérrez-Ibarluzea I
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):197-204. PubMed ID: 30543575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
    Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
    PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
    Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
    Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.